Title: Deng C, et al. The novel IKK2 inhibitor LY2409881 potently synergizes with histone deacetylase inhibitors in preclinical models of lymphoma through the downregulation of NF-κB. Clin Cancer Res. 2015 Jan 1;21(1):134-45.
946518-60-1
625095-61-6 | Pradefovir mesylate | AA01EOE2 | MFCD08435984
2102196-57-4 | FAA1 agonist-1 | AA01EOJU | MFCD31619242
1473450-62-2 | NITD-349 | AA01EOP7 | MFCD31630740
337506-43-1 | 1-[(2-chloro-5-nitrophenyl)sulfonyl]-2-methyl-1H-benzimidazole | AA01EOX4 | MFCD01173148
1895916-79-6 | 9-[(1-oxooctadecyl)oxy]-octadecanoicacid | AA01EP76
23609-41-8 | N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide,monohydrochloride | AA01EPFX
1821908-49-9 | 2S-amino-N-[[4-(3,5-dimethylphenoxy)-3-methylphenyl]methyl]-propanamide,monohydrochloride | AA01EPLB | MFCD30537226
101365-58-6 | 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide,monohydrochloride | AA01EPRR
65641-84-1 | 6,7-dihydro-quinazolino[3,2-a][1,4]benzodiazepine-5,13-dione | AA01EQ0J
1184971-51-4 | 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl-4,4,5,5-d4)quinoxalin-6-amine | AA01EQ7K